DE2161897A1 - Calciumionen enthaltende Lösung zur Behandlung von Calciummangel - Google Patents
Calciumionen enthaltende Lösung zur Behandlung von CalciummangelInfo
- Publication number
- DE2161897A1 DE2161897A1 DE19712161897 DE2161897A DE2161897A1 DE 2161897 A1 DE2161897 A1 DE 2161897A1 DE 19712161897 DE19712161897 DE 19712161897 DE 2161897 A DE2161897 A DE 2161897A DE 2161897 A1 DE2161897 A1 DE 2161897A1
- Authority
- DE
- Germany
- Prior art keywords
- calcium
- treatment
- solution
- deficiency
- solution containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010006956 Calcium deficiency Diseases 0.000 title claims description 6
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 title claims description 3
- 229910001424 calcium ion Inorganic materials 0.000 title claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 18
- 229960005069 calcium Drugs 0.000 claims description 18
- 229910052791 calcium Inorganic materials 0.000 claims description 18
- 239000011575 calcium Substances 0.000 claims description 18
- 229960000259 magnesium asparaginate Drugs 0.000 claims description 8
- 239000004227 calcium gluconate Substances 0.000 claims description 7
- 229960004494 calcium gluconate Drugs 0.000 claims description 7
- 235000013927 calcium gluconate Nutrition 0.000 claims description 7
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 7
- ZHYLJCKTXNWNPJ-CEOVSRFSSA-L magnesium;(2s)-2,4-diamino-4-oxobutanoate Chemical compound [Mg+2].[O-]C(=O)[C@@H](N)CC(N)=O.[O-]C(=O)[C@@H](N)CC(N)=O ZHYLJCKTXNWNPJ-CEOVSRFSSA-L 0.000 claims description 7
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 claims description 6
- 239000004281 calcium formate Substances 0.000 claims description 6
- 229940044172 calcium formate Drugs 0.000 claims description 6
- 235000019255 calcium formate Nutrition 0.000 claims description 6
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 6
- 239000001527 calcium lactate Substances 0.000 claims description 6
- 229960002401 calcium lactate Drugs 0.000 claims description 6
- 235000011086 calcium lactate Nutrition 0.000 claims description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 241000282849 Ruminantia Species 0.000 claims description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 claims description 2
- ISYHFARMUCCYDZ-DKWTVANSSA-N (2s)-2-aminobutanedioic acid;magnesium Chemical compound [Mg].OC(=O)[C@@H](N)CC(O)=O ISYHFARMUCCYDZ-DKWTVANSSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 description 12
- 235000013336 milk Nutrition 0.000 description 9
- 239000008267 milk Substances 0.000 description 9
- 210000004080 milk Anatomy 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 241000283690 Bos taurus Species 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 159000000007 calcium salts Chemical class 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 208000007542 Paresis Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010049993 Cardiac death Diseases 0.000 description 1
- 206010011906 Death Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1717970 | 1970-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2161897A1 true DE2161897A1 (de) | 1972-07-06 |
Family
ID=20303340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712161897 Pending DE2161897A1 (de) | 1970-12-17 | 1971-12-14 | Calciumionen enthaltende Lösung zur Behandlung von Calciummangel |
Country Status (5)
| Country | Link |
|---|---|
| DE (1) | DE2161897A1 (xx) |
| FR (1) | FR2118132A1 (xx) |
| GB (1) | GB1324937A (xx) |
| IE (1) | IE35902B1 (xx) |
| NL (1) | NL7117054A (xx) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0667152A1 (de) * | 1994-01-28 | 1995-08-16 | Chevita GmbH | Orale Verwendung von Calciumformiat zur Behandlung von Calciumdefizienz bei Tieren |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4738856A (en) * | 1985-05-13 | 1988-04-19 | Nutrition Technologies, Inc. | Beverage and method for making a beverage for the nutritional supplementation of calcium in humans |
| AT407483B (de) * | 1999-08-06 | 2001-03-26 | Sanochemia Pharmazeutika Ag | Veterinärmedizinisches mittel zum verabreichen von kalzium |
-
1971
- 1971-12-13 NL NL7117054A patent/NL7117054A/xx unknown
- 1971-12-14 DE DE19712161897 patent/DE2161897A1/de active Pending
- 1971-12-16 FR FR7145260A patent/FR2118132A1/fr not_active Withdrawn
- 1971-12-16 IE IE159371A patent/IE35902B1/xx unknown
- 1971-12-16 GB GB5846371A patent/GB1324937A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0667152A1 (de) * | 1994-01-28 | 1995-08-16 | Chevita GmbH | Orale Verwendung von Calciumformiat zur Behandlung von Calciumdefizienz bei Tieren |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7117054A (xx) | 1972-06-20 |
| IE35902B1 (en) | 1976-06-23 |
| IE35902L (en) | 1972-06-17 |
| FR2118132A1 (xx) | 1972-07-28 |
| GB1324937A (en) | 1973-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1793315C2 (xx) | ||
| DE2712786C2 (xx) | ||
| DE1792295B1 (de) | Pharmazeutisches Praeparat enthaltend 1-Aminomethyladamantan | |
| DE69529213T2 (de) | Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten | |
| DE2414593A1 (de) | Arzneimittel und verfahren zu seiner herstellung | |
| DE2329158A1 (de) | Heilmittel zur behandlung der ketonaemie und der osteomalazie bei vieh, insbesondere hornvieh | |
| EP0245669B1 (de) | Pharmazeutisches Präparat zur Verhütung der Schädigung lebender Zellen durch freie Radikale, beziehungsweise zur Erhöhung der Wirksamkeit von organischen Schwefelverbindungen und Verfahren zur Erhöhung der Lebensdauer isolierter Organe | |
| DE2021982A1 (de) | Verwendung von 25-Hydroxycholecalciferol zur Behandlung und Prophylaxe der Milchkrankheit bei Milchvieh | |
| DE2161897A1 (de) | Calciumionen enthaltende Lösung zur Behandlung von Calciummangel | |
| DE3613167A1 (de) | Verwendung von tnf zur herstellung von arzneimitteln | |
| DE60216292T2 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
| DE3153623C2 (xx) | ||
| DE2720288C2 (de) | Verwendung von Magnesiumsalzen zur Herstellung von Zubereitungen zur Behandlung von Nutztieren | |
| EP0018550B1 (de) | Mittel zur Behandlung von Muskelerkrankungen | |
| DE2831964C2 (xx) | ||
| DE1492075C3 (de) | Kosmetisches Mittel zur Unterstützung der Behandlung bei Haarausfall und/oder Seborrhoe sowie Verfahren zur Herstellung derselben | |
| Groh et al. | ORALE DAUERTHERAPIE MIT CLONAZEPAM (Ro 5‐4023) BEI EPILEPSIEN DES KINDES‐UND JUGENDALTERS | |
| DE102024112758B3 (de) | Zusammensetzung zur Behandlung von neurologischen Post-Virus-Infektionssyndromen | |
| AT518982B1 (de) | Arzneimittel gegen männliche Sterilität | |
| DE1767352C (de) | Subkutan zu verabreichendes Veterinär-Arzneimittel zur Verbesserung des Fleischansatzes | |
| DE1923167A1 (de) | Aminosaeureloesung zur intravenoesen Stickstoffzufuhr bei uraemischen Bedingungen und Verfahren zu deren Herstellung | |
| Jonason et al. | Tierversuche mit beschleunigter Rotation | |
| EP0788355B1 (de) | Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten | |
| DE1792295C (de) | Pharmazeutisches Präparat enthaltend 1-Aminomethyladamantan. Ausscheidung aus: 1468769 | |
| DE2511588A1 (de) | Neues mittel zur prophylaxe und therapie von dehydratationen in der veterinaermedizin, verfahren zu dessen herstellung und seine neue anwendung |